| References: |
CB-839 is an investigational drug that works by inhibiting an enzyme involved in cancer metabolism called glutaminase. CB-839 has been shown to halt the growth of or kill cancer cells across a range of tumor types. The compound has demonstrated antitumor activity in several different tumor models in animals. In preclinical toxicology studies, CB-839 was well tolerated in animals at doses above those shown to inhibit tumor growth. CB-839 has also shown strong synergy with immunomodulatory agents and several kinase inhibitors that target growth factor pathways.
For the detailed information of CB-839, the solubility of CB-839 in water, the solubility of CB-839 in DMSO, the solubility of CB-839 in PBS buffer, the animal experiment (test) of CB-839, the cell expriment (test) of CB-839, the in vivo, in vitro and clinical trial test of CB-839, the EC50, IC50,and affinity,of CB-839, For the detailed information of CB-839, the solubility of CB-839 in water, the solubility of CB-839 in DMSO, the solubility of CB-839 in PBS buffer, the animal experiment (test) of CB-839, the cell expriment (test) of CB-839, the in vivo, in vitro and clinical trial test of CB-839, the EC50, IC50,and affinity,of CB-839, Please contact DC Chemicals. |
